Glepaglutide

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameGlepaglutide
Drug Alias NameZP-1848
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsRenal InsufficiencyShort Bowel SyndromeInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesZealand Pharma A/SOberland Capital Management LLC
Inactive CompaniesN/A
Active IndicationsShort Bowel Syndrome
Inactive IndicationsRenal InsufficiencyInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG